Delaying Chemotherapy in Breast Cancer Patients Reduces Overall Survival

December 2015


New Study Finds Delaying Chemotherapy in Breast Cancer Patients Reduces Overall Survival Rate

A new study finds delaying the start of adjuvant chemotherapy for more than 90 days following surgery may significantly increase the risk of death for breast cancer patients, particularly those with triple-negative breast cancer.

Researchers found those most likely to have delayed chemotherapy share these characteristics - low socioeconomic status, Hispanic or African-American descent and those with Medicare and Medicaid coverage. The Cancer Prevention Institute of California (CPIC) Research Scientist Christina A. Clarke, Ph.D., and Epidemiologist in Surveillance Research Daphne Y. Lichtensztajn, M.D., served as co-authors of this study. Read the press release from The University of Texas MD Anderson Cancer Center.


Breast Cancer Family Registry Reaches 20 Year Milestone

In 1995, the National Cancer Institute established the Breast Cancer Family Registry at six international centers to study the genetic origins of breast cancer.

To find the genes that cause breast cancer and identify high risk factors in women, a breast cancer patient, her sisters, mother, and other relatives are asked to participate in a study.

The Northern California Family Registry for Breast Cancer at CPIC has enrolled and followed 4,000 multigenerational families for 20 years.

The information gathered through this study has contributed many new insights into the genetics of breast cancer.

Among these enrolled participants, there is a substantial representation of racial/ethnic minority families (accounting for 75 percent of families enrolled) and families with triple negative breast cancers - a particularly difficult to treat type of breast cancer.

View the infographic for an overview of the major milestones.


Esther M. John Named CPIC Director of Research

Esther M. John Ph.D., M.S.P.H., a well-respected cancer epidemiologist in the scientific community, was appointed director of research for CPIC last month. She has been with CPIC since 1994. Dr. John is also a consulting professor in the Department of Health Research and Policy at the Stanford University School of Medicine, and co-leader of population sciences at the Stanford Cancer Institute.

Her research focuses on identifying factors that contribute to racial/ethnic disparities in breast and prostate cancer development and prognosis. Dr. John collaborates with many research groups, and leads the Northern California site of several international multicenter studies, including the Breast Cancer Family Registry, the WECARE (Women's Environment Cancer and Radiation Epidemiology) study, and the LEGACY Girls Study.


Donor Profile – Sandi Farrell

Sandi Farrell worked for CPIC for over 20 years before retiring this past summer. Her story serves as an important reminder that each of us has the capacity to give and of the many ways to do so. Over the duration of her career with CPIC, she chose to donate a percentage of her salary to CPIC through a tax-deductible payroll deduction.

She began her career at CPIC as a part-time receptionist which eventually led to a role of providing administrative support to the community education program and development office. In this role, she experienced firsthand the importance of our community education programs for cancer survivors. She later served as the executive assistant to the CEO and Board of Trustees. 

Like so many of us, she lost a loved one to cancer – her father. She chose to give to CPIC because she strongly believes in cancer prevention. In her words, “I was proud to work with an organization that is working to prevent cancer so other families won't have to experience the loss of a loved one from this disease.”

Does your company offer an employer giving match program? Contact us to share your company information.


15th Annual Breast Cancer Conference – Save the Date

On Saturday, March 19th breast cancer survivors, family and friends are invited to gather in San Francisco at the Presidio to hear cancer specialists from leading medical institutions address breast cancer treatment and related issues at the 15th Annual Allison Taylor Holbrooks/Barbara Jo Johnson Breast Cancer Conference.

The goal of the conference is to help patients, families, friends and health care providers to understand their options so that informed decisions about health and health care can be made. Local and national information resources will also be available.

Registration will open in January. The fee is only $20 and no one will be turned away for lack of funds. Space is limited.

Visit the CPIC website to learn more about the conference or to request a brochure.


Rosemary and Pear Muffins – A Recipe from the Cancer-Fighting Kitchen Cookbook 

This month we’re sharing another recipe from the The Cancer-Fighting Kitchen cookbook featuring 150 nutrient-rich and easy-to-prepare recipes that will help to stimulate the appetite and relieve some of the treatment side effects for cancer patients.

For many of us, the holidays are about enjoying warm baked goods. These rosemary and pear muffins are quick and easy to make and offer health benefits. Rosemary aids with digestion, circulation and immune function.

Since these muffins are small, cancer patients, who often don’t have a strong appetite, won’t be overwhelmed by their size.


Get the Latest on Personalized Medicine & the Patient Experience 

How is today’s patient experience different than before due to the emergence of personalized medicine and the Affordable Care Act? At the Personalized Medicine World Conference (PMWC) 2016 Silicon Valley, a “real world” patient experience will be examined through multiple lenses.

From diagnosis and treatment to ongoing disease management and paying for advanced care, the convergence of scientific advancement and a challenging medical economy has created a new paradigm. What is working and what challenges remain? Get educated at PMWC 2016 SV, co-hosted with Stanford Health Care and the University of California, San Francisco on January 24-27 alongside leaders from healthcare, medical research and drug development, health regulators, and representatives from the insurance industry, as well as patients and patient advocates. Learn more.


© Cancer Prevention Institute of California